| Characteristics | Effective (n | Percentage % |
| AGE |
|
|
| Average | 52 ± 12.5 years |
|
| Middle level | 51 years |
|
| Extrem | 18 - 95 years |
|
| AGE SLICE |
|
|
| [18 - 33] | 38 | 5.8 |
| [34 - 49] | 236 | 36.3 |
| [50 - 65] | 288 | 44.2 |
| [66 - 81] | 81 | 12.4 |
| [82 - 97] | 8 | 1.2 |
| Total | 651 | 100.0 |
| HISTOLOGICAL TYPE |
|
|
| Carcinomic Epidermoïde | 613 | 94.2 |
| Adenocarcinome | 33 | 5.1 |
| Carcinome a clear cell | 3 | 0.5 |
| Leiomysarcome | 1 | 0.2 |
| Sarcome stromal | 1 | 0.2 |
| Total | 651 | 100.0 |
| Symptomatology discovery |
|
|
| Metrorragy | 601 | 92.3 |
| Hydrorrhee or Leucorrhee only | 11 | 1.7 |
| Pelvic pains | 8 | 1.3 |
| Dysury | 2 | 0.3 |
| Digestive signs (Diarrhea or constipation) | 5 | 0.7 |
| Mix symptoms | 24 | 3.7 |
| Stadification FIGO |
|
|
| IB | 5 | 0.8 |
| IIA | 9 | 1.4 |
| IIB | 30 | 4.6 |
| IIIA | 94 | 14.4 |
| IIIB | 429 | 65.9 |
| IVA | 57 | 8.8 |
| IVB | 27 | 4.1 |
| Total | 651 | 100.0 |